A new study published in the British Medical Journal (BMJ) has found that some hormonal contraceptives, particularly those ...
Dr. Ebenezer Quainoo is a medical professional whose career has been defined by a dedicated approach to healthcare.
The study revealed the risk of developing venous thromboembolisms from various types of synthetic hormones, providing ...
QLS‑111 is a novel topical formulation using Qlaris Bio’s ATP-sensitive potassium channel modulator platform. QLS-111 lowers ...
A systematic review and meta-analysis estimating the differences in bleeding risks between therapeutic-dose non-vitamin K oral anticoagulants (NOACs) and single antiplatelet therapy (aspirin) found ...
Two-year follow-up data from 34 subjects in the VenoValve pivotal trial show sustained clinical improvement and continued patient benefit, from 12 months to 24 months.